Page last updated: 2024-11-01

nimodipine and Adenocarcinoma, Papillary

nimodipine has been researched along with Adenocarcinoma, Papillary in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Adenocarcinoma, Papillary: An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mattsson, P1
Björck, G1
Remahl, S1
Bäckdahl, M1
Hamberger, B1
Hydman, J1
Svensson, M1

Other Studies

1 other study available for nimodipine and Adenocarcinoma, Papillary

ArticleYear
Nimodipine and microsurgery induced recovery of the vocal cord after recurrent laryngeal nerve resection.
    The Laryngoscope, 2005, Volume: 115, Issue:10

    Topics: Adenocarcinoma, Papillary; Adult; Calcium Channel Blockers; Humans; Male; Microsurgery; Nerve Regene

2005